These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18362500)

  • 1. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy.
    Li JH; Zhang N; Wang JA
    J Endocrinol Invest; 2008 Feb; 31(2):103-10. PubMed ID: 18362500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy.
    Zhang N; Li J; Luo R; Jiang J; Wang JA
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of bone marrow mesenchymal stem cell transplantation on diabetic cardiomyopathy].
    ZHANG N; LI JH; WANG JA; ZHANG HK
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1115-9. PubMed ID: 19134282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen.
    Shabbir A; Zisa D; Suzuki G; Lee T
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1888-97. PubMed ID: 19395555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats.
    Shibata T; Naruse K; Kamiya H; Kozakae M; Kondo M; Yasuda Y; Nakamura N; Ota K; Tosaki T; Matsuki T; Nakashima E; Hamada Y; Oiso Y; Nakamura J
    Diabetes; 2008 Nov; 57(11):3099-107. PubMed ID: 18728233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.
    Yoon YS; Uchida S; Masuo O; Cejna M; Park JS; Gwon HC; Kirchmair R; Bahlman F; Walter D; Curry C; Hanley A; Isner JM; Losordo DW
    Circulation; 2005 Apr; 111(16):2073-85. PubMed ID: 15851615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats.
    Cheng Y; Guo S; Liu G; Feng Y; Yan B; Yu J; Feng K; Li Z
    Int J Mol Med; 2012 Oct; 30(4):870-6. PubMed ID: 22859217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
    Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
    Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-β1/Smad2 signaling pathway.
    Lin Y; Zhang F; Lian XF; Peng WQ; Yin CY
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):123-126. PubMed ID: 31880529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The protective effect of pigment epithelial-derived factor modified human umbilical cord mesenchymal stem cells on rats with diabetic retinopathy].
    Zhang W; Duan HT; Chen S; Wang YX; Kong JH; Dong M; Bi X; Song J
    Zhonghua Yan Ke Za Zhi; 2017 Jul; 53(7):540-547. PubMed ID: 28728289
    [No Abstract]   [Full Text] [Related]  

  • 14. Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury.
    Zuo S; Jones WK; Li H; He Z; Pasha Z; Yang Y; Wang Y; Fan GC; Ashraf M; Xu M
    Stem Cells Dev; 2012 Mar; 21(4):598-608. PubMed ID: 21463175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2.
    Jin L; Zhang J; Deng Z; Liu J; Han W; Chen G; Si Y; Ye P
    Stem Cell Res Ther; 2020 Mar; 11(1):122. PubMed ID: 32183879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.
    Ciuffreda MC; Malpasso G; Chokoza C; Bezuidenhout D; Goetsch KP; Mura M; Pisano F; Davies NH; Gnecchi M
    Acta Biomater; 2018 Apr; 70():71-83. PubMed ID: 29341932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats.
    Monnerat-Cahli G; Trentin-Sonoda M; Guerra B; Manso G; Ferreira AC; Silva DL; Coutinho DC; Carneiro-Ramos MS; Rodrigues DC; Cabral-da-Silva MC; Goldenberg RC; Nascimento JH; Campos de Carvalho AC; Medei E
    Int J Cardiol; 2014 Feb; 171(2):199-208. PubMed ID: 24374203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia.
    Tsubokawa T; Yagi K; Nakanishi C; Zuka M; Nohara A; Ino H; Fujino N; Konno T; Kawashiri MA; Ishibashi-Ueda H; Nagaya N; Yamagishi M
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1320-9. PubMed ID: 20154257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stromal cells with CD47 high expression via the signal transducer and activators of transcription signaling pathway preventing myocardial fibrosis.
    Deng W; Chen QW; Li XS; Yuan ZM; Li GQ; Ke DZ; Wang L; Wu ZQ; Luo SL
    Int J Clin Exp Pathol; 2015; 8(9):10555-64. PubMed ID: 26617765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.
    Nagaya N; Kangawa K; Itoh T; Iwase T; Murakami S; Miyahara Y; Fujii T; Uematsu M; Ohgushi H; Yamagishi M; Tokudome T; Mori H; Miyatake K; Kitamura S
    Circulation; 2005 Aug; 112(8):1128-35. PubMed ID: 16103243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.